Details for Patent: 12,043,626
Which drugs does patent 12,043,626 protect, and when does it expire?
Patent 12,043,626 protects JIDEYTRO and is included in one NDA.
This patent has ten patent family members in ten countries.
Summary for Patent: 12,043,626
| Title: | Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds |
| Abstract: | Provided herein are solid forms comprising a compound of formula (I), or a stereoisomer, or a mixture of stereoisomers thereof, or a pharmaceutically acceptable salt thereof. Also provided herein are methods of synthesizing a compound of formula (I), pharmaceutical compositions comprising the same, and methods of treating, preventing, and managing various disorders using the compositions provided herein. |
| Inventor(s): | Sibao Chen, Christopher G. F. COOPER, Baudouin Gerard, Joshua Courtney Horan, Jason T. KROPP, Benjamin Stephen LANE, David James Pearson |
| Assignee: | Nuvalent Inc |
| Application Number: | US17/957,725 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 12,043,626
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nuvalent | JIDEYTRO | zidesamtinib | TABLET;ORAL | 220185-001 | Jul 22, 2026 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| Nuvalent | JIDEYTRO | zidesamtinib | TABLET;ORAL | 220185-002 | Jul 22, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,043,626
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2022357554 | ⤷ Start Trial | |||
| Canada | 3231813 | ⤷ Start Trial | |||
| China | 118234725 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
